Balaji Amines Limited
BALAMINES · NSE · Basic Materials
With a 20% margin of safety, our buy-below price is ₹874.65.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%8.1%
- ✓Low debt (D/E < 0.5)0.06x
- ✕Positive free cash flow
- ✓Revenue growth > 10%12%
- ✓Earnings growing62%
- ✓Net margin ≥ 10%11.7%
- ✓Current ratio > 1.52.34
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 8.43
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-16Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Analyst views
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 8.43.
Opportunities
- •Earnings growing (62% YoY).
Threats
- •Rich valuation versus sector peers.
- •Trades ~47% above our estimated fair value.
About Balaji Amines Limited
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyro
More in Basic Materials
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.